A state-of-the-art device to expand the peripheral field for those who have a visual field loss following a CVA or TBI.
PAVE™
Visual field loss following a CVA or TBI often affects bilateral fields (homonymous hemianopia). The field loss is thought to occur due to injury in an area of the occipital cortex or visual portion of the brain related to either the left or right visual field.
The prevalence of Traumatic Brain Injury (TBI) in the world is between 30-60 million people and the prevalence of CVA accounts for 86 million people world-side.
Persons with a homonymous hemianopsia:
- Lose independence.
- Are unable to drive an automobile.
- Have increased fall risk and risk of injury.
- Are told that they should wait a year and if the visual filed loss is still present then it will remain for the rest of their lives.
The Parallactic-Visual-field Enhancement (PAVE™) instrument is a state-of-the-art device to expand the peripheral field for those who have a visual field loss following a CVA or TBI. A feature common to all product lines is that they provide new capabilities in the area of diagnosis and rehabilitation through vision. Recent scientific research in the area of neuro-visual processing has identified visual functions critical to neuro-visual processing organization, sensorimotor and neuro-motor systems. Existing standard equipment found in offices of ophthalmologists or optometrists as well as rehabilitation hospitals, clinics or offices cannot measure these newly identified functions.
- Provides rehabilitation to rehabilitate and enhance the visual field.
- Utilizes a state-of-the-art virtual headset.
- Can be used in a doctor’s office, hospital, rehabilitation center and can be adapted for home use.
- Cloud based device.
- Lightweight.
- Can be run remotely.
- Clinician can change and update the program remotely.
- Visual field changes can be compared over time.
- Affects quality of life experience by enabling patients to return to work, gain independence, drive, return to employment, etc.
- Multilingual
